South Korea Pharmaceutical Market Outlook 2013

By Author: Bharat Book Bureau
Total Articles: 1486
Comment this article

May 21, 2013: Bharat Book Bureau presents the market report South Korea Pharmaceutical Market Outlook 2013 provides in-depth analysis of the trends, issues and challenges facing the South Korean pharmaceutical market.

“South Korea Pharmaceutical Market Outlook 2013” provides in-depth analysis of the trends, issues and challenges facing the South Korean pharmaceutical market. The report also provides competitive benchmarking for the country’s leading pharmaceutical companies and analyzes the M&A (Mergers and Acquisitions) and strategic partnerships that shape its pharmaceutical industry. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

The South Korean pharmaceutical market is the 10th largest pharmaceutical market, globally. The industry is highly fragmented, with almost all the domestic pharmaceutical companies having a strong portfolio of generic products rather than expensive, branded drugs. For the entire pharmaceutical industry, an increase in insurance coverage, an ageing ...
... population and favorable government initiatives are expected to drive future growth in the pharmaceutical industry.

Improved Intellectual Property Rights (IPR), changing demographics, and government support have contributed towards making the South Korean pharmaceutical industry attractive for multinational companies. The South Korean government has signed Free Trade Agreements (FTA) with the US, Europe and India that are aimed at improving the IPR framework in the country and making the pharmaceutical industry more attractive for foreign investment. The immediate effects of the FTA may not be positive in all respects for the generics-dominated domestic pharmaceutical industry. However, it is ultimately expected to bolster the South Korean pharmaceutical industry by increasing transparency in government policies and enforcement, and price competition in the private sector.

Scope

- The macroeconomic environment of the pharmaceutical industry in South Korea, covering demographic analysis, trends, drivers and barriers
- Important industry characteristics, including the regulatory authorities, drug pricing, spending, insurance and reimbursement
- Market analysis of segments such as prescription medicines, biotechnology and over-the-counter medicines
- Competitive profiling of major domestic and international companies operating in the South Korea pharmaceutical market
- Analyses of the licensing, partnership and M&A deals that took place between 2007 and 2012

Reasons to buy

- Develop market-entry and market-expansion strategies by identifying the leading segments poised for strong growth
- Devise a more specifically-tailored country strategy through understanding the key drivers and barriers for the pharmaceutical market
- Develop key strategic initiatives by understanding leading companies’ key focus areas
- Accelerate and strengthen your market position by identifying key companies for M&As and strategic partnerships

Companies Mentioned

GlaxoSmithKline
Sanofi
Pfizer
Dong-A
Green Cross
Hanmi
JW Holdings Corporation (Choongwae Holdings Co., Ltd.)
Yuhan Corporation
Table of Contents

1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 7
1.2 List of Figures 8
2 Introduction 9
3 South Korea Pharmaceutical Market Outlook 2013 – Overview 10
3.1 Global Pharmaceutical Industry Landscape 10
3.2 Macroscopic View of the South Korea Pharmaceutical Market 10
3.3 Trade Balance 12
3.3.1 Exports 13
3.3.2 Imports 16
3.4 Demographic Analysis 18
3.4.1 Population Size, Growth, and Structure 18
3.4.2 Crude Death Rate 19
3.4.3 Causes of Death 20
3.4.4 Crude Birth Rate 22
3.4.5 Infant Mortality Rate 23
3.4.6 Life Expectancy at Birth 24
3.4.7 Comparison of Healthcare Indicators 25
3.5 Driver and Barriers of South Korean Pharmaceutical Industry 26
3.5.1 Drivers 26
3.5.2 Barriers 28
4 South Korea Pharmaceutical Market Outlook 2013 – Industry Characteristics 29
4.1 Regulatory Agencies 29
4.1.1 Korea Food and Drug Administration 29
4.1.2 National Institute of Food and Drug Safety Evaluation 30
4.2 Drug Pricing Policy 31
4.3 Healthcare Expenditure in South Korea 32
For more information kindly visit  : http://www.bharatbook.com/healthcare-market-research-reports/south-korea-pharmaceutical-market-outlook-2013.html

Or
Contact Us at:
 Bharat Book Bureau
 Tel: +91 22 27810772 / 27810773
 Call UK: +44 7405 208461
 Toll Free No for USA/Canada : 1-866-279-8368
 Email: info@bharatbook.com
 Website: www.bharatbook.com
 Follow us on twitter: https://twitter.com/researchbook
 Follow us on linkedin : http://www.linkedin.com/company/bharat-book-bureau
 Our Blog : http://blog.bharatbook.com/